Search results for Afasevikumab Biosimilar – Anti-IL17A , IL17F mAb – Research Grade
Showing 1 – 10 of1products
ID: BAB049733112
Afasevikumab Biosimilar – Anti-IL17A , IL17F mAb – Research Grade, ProteoGenix, PX-TA1401
Description of Afasevikumab Biosimilar - Anti-IL17A , IL17F mAb - Research Grade General information on Anti-IL17A /IL17F[Homo sapiens] (Afasevikumab) Monoclonal Antibody Afasevikumab is a monoclonal antibody that targets IL17 and is investigated for the treatment of Multiple Sclerosis(MS).
Host
Reactivity
Applications
Conjugation
Request a product
Please provide the required information below so that we can quickly source your products.